/home/corante/public_html/pipeline/ en-us derekb.lowe@gmail.com 2012-02-10T13:03:49-05:00 hourly 1 2000-01-01T12:00+00:00 http://pipeline.corante.com/archives/2012/02/10/the_terrifying_cost_of_a_new_drug.php Matthew Herper at Forbes has a very interesting column, building on some data from Bernard Munos (whose work on drug development will be familiar to readers of this blog). What he and his colleague Scott DeCarlo have done is conceptually... 75449@/home/corante/public_html/pipeline/ Drug Prices 2012-02-10T13:03:49-05:00 http://pipeline.corante.com/archives/2012/02/08/buying_back_shares_an_admission_of_defeat.php Announcing layoffs along with a stock buyback - let's think about what that means. AstraZeneca did that just the other day, and they're far from the only ones in this industry (or others) spending billions to buy back their own... 75440@/home/corante/public_html/pipeline/ Business and Markets 2012-02-08T07:44:06-05:00 http://pipeline.corante.com/archives/2012/02/03/astrazeneca_in_waltham.php From several reports, here's what I have on AstraZeneca's plans in Waltham: they've told people there that cuts are coming. But they haven't gotten very specific on when, or who, or how many. All those questions (that is, all the... 75425@/home/corante/public_html/pipeline/ Business and Markets 2012-02-03T07:26:50-05:00 http://pipeline.corante.com/archives/2012/02/01/astrazeneca_layoffs_and_closings.php Update: it's all true. 7,300 job cuts in total. Montreal and Soedertaelje (Sweden) to close. And AZ seems to be all but getting out of pain/CNS, cutting down to a few dozen people who will do external collaborations. Oh, and... 75423@/home/corante/public_html/pipeline/ Business and Markets 2012-02-01T21:50:20-05:00 http://pipeline.corante.com/archives/2012/01/31/astrazeneca_cutting_even_more.php OK, this is one of those less-than-cheerful mornings on the blog, apparently. Word is in the British press that AstraZeneca is preparing to announce thousands more job cuts later this week. No more concrete details yet - all the company... 75418@/home/corante/public_html/pipeline/ Business and Markets 2012-01-31T10:56:01-05:00 http://pipeline.corante.com/archives/2012/01/27/roche_goes_hostile_for_illumina.php Roche is not only a big drug company, it's a big diagnostics company. And that's what's driving their unsolicited bid for Illumina, a gene-sequencing company from San Diego. Illumina has been one of the big players in the "How quickly... 75410@/home/corante/public_html/pipeline/ Business and Markets 2012-01-27T09:39:23-05:00 http://pipeline.corante.com/archives/2012/01/20/alnylam_cuts_back_hard.php The news is that Alnylam, the RNAi company just down the street from where I'm writing, is cutting about a third of its workforce to try to get its best prospects through the clinic. This is a familiar story in... 75391@/home/corante/public_html/pipeline/ Business and Markets 2012-01-20T08:52:06-05:00 http://pipeline.corante.com/archives/2012/01/19/takeda_announces_cuts.php 2,800 over the next four years. More of them are in Europe than in the US (via the Nycomed acquisition), but there are hundreds of positions to be lost in this country, too. For now, the company seems to be... 75386@/home/corante/public_html/pipeline/ Business and Markets 2012-01-19T09:09:07-05:00 http://pipeline.corante.com/archives/2012/01/17/warp_drive_bio_best_name_or_worst.php There are small drug firms and there are small drug firms - if you know what I mean. Which category is Warp Drive Bio going to fall into? If you've never heard of them - and that name is rather... 75382@/home/corante/public_html/pipeline/ Business and Markets 2012-01-17T11:28:49-05:00 http://pipeline.corante.com/archives/2012/01/17/newhouse_research.php Looks like the former Merck site in Newhouse is beginning to get some tenants as part of "Biocity Scotland". I wish everyone involved good luck - we need more smaller firms, because that's the only way to get larger firms.... 75381@/home/corante/public_html/pipeline/ Business and Markets 2012-01-17T11:22:02-05:00 http://pipeline.corante.com/archives/2012/01/12/sanofis_bridgewater_site_closing_this_week.php Someone in a position to know has told me that Sanofi's Bridgewater, NJ site, which has long been a focus of layoffs, is now closing even faster than people thought. Originally, it was supposed to be "by the end of... 75373@/home/corante/public_html/pipeline/ Business and Markets 2012-01-12T08:44:28-05:00 http://pipeline.corante.com/archives/2012/01/12/welcome_to_the_jungle_heres_your_panther.php English has no word of its own for schadenfreude, so we've had to appropriate the German one, and we're in the process of making it our own - just as we did with "kindergarten", not to mention "ketchup" and "pyjamas",... 75372@/home/corante/public_html/pipeline/ Business and Markets 2012-01-12T07:45:58-05:00 http://pipeline.corante.com/archives/2012/01/09/the_jp_morgan_myths.php The JP Morgan Healthcare Conference is underway this week out in San Francisco, so there are a lot of biotech/pharma headlines to come out of that. Luke Timmerman over at Xconomy has "Five Myths" to come out of the conference.... 75370@/home/corante/public_html/pipeline/ Business and Markets 2012-01-09T11:24:26-05:00 http://pipeline.corante.com/archives/2012/01/06/scifinder_access_for_the_unemployed.php If you had SciFinder access, but are now unemployed and would like to use it during your job hunt, CAS now has a program to make that possible for free. I'm glad to see them taking this step; a lot... 75368@/home/corante/public_html/pipeline/ Business and Markets 2012-01-06T16:05:25-05:00 http://pipeline.corante.com/archives/2012/01/04/osiris_and_their_stem_cells.php The topic of whether stem-cell therapies are overhyped - OK, let me show my cards, the topic of just how overhyped they are - last came up around here in November, when Geron announced that they were getting out of... 75363@/home/corante/public_html/pipeline/ Biological News 2012-01-04T08:21:06-05:00